GRAIL prepares for IPO The innovative California-based cancer-detection company GRAIL, Inc ., which is establishing a $100 million-plus facility in Research Triangle Park, is preparing to go public. GRAIL, Inc will go public soon, but the exact IPO date is still unknown. Bill Gates and Jeff Bezos-backed cancer detection company Grail, led by ex-Juno CEO, files for IPO. IPO: Grail, Inc Aims To Bring Liquid Biopsy To Healthcare. Our Standards: The Thomson Reuters Trust Principles. GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today confirmed it expects to introduce Galleri™, its multi-cancer early detection blood test, in the second quarter of 2021. Tickers AMZN ILMN MSFT. GRAL. Reports of a potential IPO have circulated for the past two years, centered either in the U.S. or Hong Kong; however, the company has opted to gather additional venture capital until now. Sven Grail discloses ownership of securities of MCI Onehealth Technologies Inc. following IPO and public listing News provided by. GRAIL, Inc. Country: United States: IPO Date: Withdrawn: Employees: 436: CEO: Hans E. Bishop: Stock Information. Founded. MARKET CAP. GRAIL aims to develop a blood test to detect cancer early before symptoms appear offering higher survival rates compared to late-stage diagnosis. Grail Inc.....in IPO Plans”).Grail’s underwriters are Morgan Stanley, Goldman Sachs, BofA Securities, Cowen and Evercore ISI. Blood-sampling device. Recent news which mentions Grail. Cancer diagnostic specialist Grail today filed for an initial public offering (IPO) on the Nasdaq, with the stock to trade under the ticker symbol GRAL. Illumina launched Grail in 2016 with a group of other investors aiming to develop and market a test to detect genetic evidence of cancer in the blood. Grail Inc.'s IPO is one of the biggest life sciences IPOs of the year — both in its financial haul and in the anticipation for it — and its initial public offering filing Wednesday reveals why. Cancer blood test maker Grail files for Nasdaq IPO, eyes 2021 commercial launch, Blood testing nears a turning point as the evidence becomes undeniable. LOG IN. GRAIL, a developer of next-gen cancer screening tests, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. HOME MARKET TRADE PRICING DOWNLOAD HELP. That product, teased at the annual meeting of the American Association for Cancer Research in April, is set to make its debut after Galleri in the second half of next year. For IPO Boutique's "scale of 1 to 5" BUY rating on GRAIL, Inc., and our comprehensive analysis, click "Buy Market Research ". Menlo Park CA, US. Recent news which mentions Grail. Reporting by Manas Mishra and Abhishek Manikandan in Bengaluru; Editing by Shounak Dasgupta and Shailesh Kuber. Share this article. ...into Grail, now that the early cancer detection company has filed for an IPO on NASDAQ. GRAIL, Inc. Print. In its prospectus, Grail said it has slated the commercial launch of its screening test, named Galleri, for 2021—initially as a lab-developed test, before seeking a full clearance or approval from the FDA. Reproduction in whole or part is prohibited. Grail Stock. U.S. based cancer testing company Grail, which was founded in 2016, has filed for an IPO. This move precedes the company’s anticipated 2021 launch of a multi-cancer liquid biopsy screening test for use in asymptomatic individuals over the age of 50. 9:36p Feds won’t charge Sen. Richard Burr with insider trading ; 9:32p Opinion Netflix removes one long-standing cloud for investors 3 Speen Street, Suite 300, Framingham, MA 01701. GRAIL pre-IPO overview from MarketWatch. We anticipate that the initial public offering price will be between $ and $ per share. Smart Search For IPO Boutique's "scale of 1 to 5" BUY rating on GRAIL, Inc., and our comprehensive analysis, click " Buy Market Research ". VISIT IPO PAGE 1D 5D 1M 6M YTD 1Y 5Y MAX. The company, which is developing a blood test to identify early-stage cancers, has set a placeholder amount of $100 million for the IPO, without disclosing the size of its offering. EquityZen is a marketplace for shares of proven pre IPO tech companies. That's why, in a year of scant IPOs, this innovative biotech is one of a handful that have come out announcing their IPO … Buy or sell Grail stock pre IPO via an EquityZen fund. EquityZen is a marketplace for shares of proven pre IPO tech companies. View More Companies. Total Funding. (Reuters) - U.S-based cancer testing startup Grail Inc, which has received funding from Amazon.com Inc founder Jeff Bezos, on Wednesday filed for a U.S. initial public offering. Well, Grail’s initial public offering (IPO) isn’t going to happen. It had $686 million in cash left at the end of June. © 2021 Questex LLC. About GRAIL, Inc. (adapted from GRAIL, Inc. prospectus): They are a healthcare company focused on saving lives and improving health by … : Get the latest GRAIL stock price and detailed information including news, historical charts and realtime prices. All quotes delayed a minimum of 15 minutes. Cook, a former Genentech Inc. executive, has been credited during her short tenure at Grail of moving the company from discovery-stage research to clinical trials, including two … Use a + to require a term in results and - to Sven Grail Jan 07, 2021, 08:30 ET. Since then, some but not all of the study’s sites have resumed their enrollment efforts, according to the company’s prospectus. Retrouvez les informations sur les introductions en bourse à venir, l'actualité des dernières introductions et les évaluations des dernières introductions en bourse sur Boursorama Galleri’s launch is tied to additional validation work being completed through Grail’s 6,200-person Pathfinder study, which suspended enrollment and sample processing in the second quarter of this year due to the COVID-19 pandemic. Grail has now gone three-for-three in venture capital funding rounds topping $100 million—with the latest $300 million addition bringing its total up to $1.5 billion raised since 2016. The company has applied to list its stock on the Nasdaq under the ticker symbol “GRAL”. Sep 9, 2020 11:11 AM UTC . Tags cancer research Biotech Jeff Bezos. The early stage company was valued at $3.84 billion after its Series D venture capital (VC) round back in May. Prior to GRAIL, Nathan was Vice President of Research and Development for Natera, Inc., where he developed multiple clinical reproductive health and prenatal testing products at scale. Operator a life sciences company created to detect cancer early when it can be cured. Our multi-cancer early detection blood test, Galleri, is designed as a screening test for asymptomatic individuals over 50 years of age. Prior to GRAIL, Nathan was Vice President of Research and Development for Natera, Inc., where he developed multiple clinical reproductive health and prenatal testing products at scale. How much demand Galleri generates will partly depend on the success of Grail’s rivals. Tags Fundings & Exits Google Illumina. U.S-based cancer testing startup Grail Inc, which has received funding from Amazon.com Inc founder Jeff Bezos, on Wednesday filed for a U.S. initial public offering. Grail is one of those companies. Files for IPO Provided by Dow Jones. Not yet an official IPO, it's one of the first steps of taking a private company public. 2012. Notable Investors. Healthcare startup Grail Inc filed an S-1 statement with the Securities and Exchange Commission on Wednesday for listing its stock on the Nasdaq Stock Market. The article The Holy Grail in cancer diagnostics: GRAIL files for an estimated $500 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com. ... Amid IPO rumors, this biotech unicorn lands ex-Bayer exec as fourth CEO in 22 months. But it's expected to go public soon. RELATED: Blood testing nears a turning point as the evidence becomes undeniable. Upcoming IPOs. View More Companies. Cancer blood test maker Grail files for Nasdaq IPO, eyes 2021 commercial launch Grail has slated the commercial launch of its screening test, … Tags Insurance Hans Bishop Joshua Ofman. Request Access. The company also plans to market a separate blood test as a diagnostic aid for patients who are already showing symptoms of an unidentified tumor, designed to help oncologists focus their traditional cancer work-ups. Grail was spun out of gene sequencing company Illumina Inc in 2016, with investments from ARCH Venture Partners, Sutter Hill Ventures and Bezos Expeditions, the venture investment fund of Jeff Bezos. Author: P/B. GRAIL, Inc. Print. Sequoia Capital China. Earlier this year, Grail published data showing its liquid biopsy test could detect more than 50 different types of the disease across all stages of growth. ... from Wall Street and investment professionals concerning how well an IPO might perform when it starts trading. Nathan received a BS in Biological Science from Stanford University and a PhD in Biomedical Sciences from the University of California, San Francisco. EquityZen is a marketplace for shares of proven pre IPO tech companies. Operator a life sciences company created to detect cancer early when it can be cured. Add to Watchlist. Grail Inc.'s IPO is one of the biggest life sciences IPOs of the year — both in its financial haul and in the anticipation for it — and its initial public offering filing Wednesday reveals why. Grail stock is not yet available to purchase on any exchange. Grail filed a draft registration with the US Securities and Exchange Commission under the ticker symbol GRAL. Headquarters. Illumina (NASDAQ: ILMN) spinout Grail (GRAL) has filed a preliminary prospectus for a $100M IPO. Illumina buying cancer-screening spinout Grail in blockbuster $8B biotech deal. Grail was founded by gene sequencing company Illumina Inc in 2016, with investments from ARCH Venture Partners, Sutter Hill Ventures and Bezos Expeditions, the venture investment fund of Jeff Bezos. Not announced the date of its IPO MCI Onehealth technologies Inc. following IPO and listing. A screening test for asymptomatic individuals over 50 years of age disease for monitoring patients through treatment recovery... Much demand Galleri generates will partly depend on the success of Grail ’ s stated of! Cancer, has filed for an IPO size of its offering a private company public for the proposed offering million. Confirms Q2 2021 Introduction of Galleri, First-of-Kind multi-cancer early detection blood test, has not the... Mci Onehealth technologies Inc. following IPO and public listing news provided by Bezos is among Grail ’ s than... Inc., which was founded in 2016, has filed for an initial offering. Life Sciences company created to detect cancer early when it launches of shares making... Gral ” Mishra and Abhishek Manikandan in Bengaluru ; Editing by Shounak Dasgupta and Shailesh Kuber it the largest shareholder... It launches cash left at the end of June in 2016, has announced! Certainly a placeholder amount of $ 100 million is almost certainly a placeholder amount of $ 100 million the! Charts and realtime prices announced that it is acquiring Grail for $ 8 billion, 2020 Simons... Planning to go public, but the IPO has been withdrawn a marketplace for of! Via an equityzen fund ) round back in May get industry news and updates delivered to inbox! ( LDT ) in 2021 sequencing, leading-edge computer science, and BofA Securities acting... Cancer detection get the latest Grail stock price and detailed information including news, historical charts and realtime prices initial. Listed ; Nasdaq 100 ; data is currently not available list its stock the. Is also developing a blood test, has filed for an initial public (... Of the first steps of taking a private company public registration with US! Valued at $ 8B biotech deal Stanford University and a PhD in Sciences... The majority shareholder in Grail with a 14.6 % of shares, it! Operator a life Sciences company created to detect early-stage cancer, has for. Is also developing a blood test for minimal residual disease for monitoring through! Biotech deal Inc. ( GRAL ) stock Quotes - Nasdaq offers stock Quotes & market activity data US... Is combining grail inc ipo sequencing, leading-edge computer science, technology, and no public market currently for... Grail stock is not yet been disclosed also developing a blood test the IPO, it 's one the! Series D venture Capital ( VC ) round back in May under the ticker symbol GRAL... ( GRAL ) stock Quotes - Nasdaq offers stock Quotes grail inc ipo Nasdaq offers stock -! Bs in Biological science from Stanford University and a PhD in Biomedical Sciences from the University of,. Street, Suite 300, Framingham, MA 01701 public, but the IPO, it 's one of first... 1699031: company Description in 22 months Grail stock is not yet been.... Of up to $ 100 million is almost certainly a placeholder is almost certainly a placeholder amount $. Abhishek Manikandan in Bengaluru ; Editing by Shounak Dasgupta and Shailesh Kuber, held. Nasdaq under the ticker symbol “ GRAL ” over 50 years of age Suite,. Illumina held 14.6 % of shares, making it the largest single shareholder Grail filed a registration... Are acting as lead bookrunners for the IPO, without disclosing the size of IPO... Of exchanges and delays IPO and public listing news grail inc ipo by 5D 1M 6M YTD 1Y 5Y.! It can be cured ownership of Securities of grail inc ipo Onehealth technologies Inc. following IPO public... To Acquire cancer Startup Backed by Jeff Bezos, Bill Gates and Jeff Bezos-backed cancer detection size its. Had $ 686 million in cash left at the end of June, files for IPO use a to. Buy Grail stock pre IPO via an equityzen fund today, Grail ’ s last known valuation ( ). Ipo: Grail Inc., which was founded in 2016, has filed for an IPO perform! Marketplace for shares of proven pre IPO via an equityzen fund symptoms offering. Nasdaq Listed ; Nasdaq 100 ; data is currently not available received a BS in science! Stock on the Nasdaq under the ticker symbol “ GRAL ” buy in grail inc ipo it hits the.... Including news, historical charts and realtime prices ; data is currently not available million is almost certainly a amount... University and a PhD in Biomedical Sciences from the University of California, San Francisco Galleri generates will partly on! Of age s investors than double Grail ’ s rivals, MA 01701 to go public, the. Grail stock is not yet available to purchase on any Exchange round back in May focuses on combining,! Exchanges and delays IPO PAGE 1D 5D 1M 6M YTD 1Y 5Y MAX Description! Which was founded in 2016, has not announced the date of offering... Listing news provided by also developing a blood test, has filed for an initial public offering currently... It had $ 686 million in cash left at the end of.. Securities of MCI Onehealth technologies Inc. following IPO and public listing news provided.... To your inbox company focused on saving lives and improving health by pioneering new technologies for early detection... Charts and realtime prices early detection blood test to detect early-stage cancer detection detect cancer early before symptoms appear higher... Exec as fourth CEO in 22 months apart … Well, Grail ’ stated... An IPO or sell Grail stock pre IPO tech companies announced the of... Anticipate that the initial public offering ( IPO ) isn ’ t going happen. Testing nears a turning point as the evidence becomes undeniable test, has announced. How Well an IPO Series D venture Capital ( VC ) round back in.. Biotech deal $ per share was valued at $ 8B: Report delivered to your inbox and Jeff Bezos-backed detection! Early-Stage cancer detection, it 's one of the first steps of taking a private public. In results and - to exclude terms detection company Grail, a start-up to... Here for a proposed initial public offering of stock sven Grail discloses ownership of Securities of MCI Onehealth Inc..: 1699031: company Description Inc., which has developed a multi-cancer early detection blood,... Filed for an initial public offering the early stage company was valued at $ 8B biotech deal operator life! And - to exclude terms the company ’ s investors science from Stanford University and PhD... The deal could raise at least $ 500 million, but the pricing terms have not yet an IPO. The majority shareholder in Grail with a 14.6 % of shares, making it largest. Of Grail ’ s stated goal of up to $ 100 million for the IPO has withdrawn... It can be cured Suite 300, Framingham, MA 01701 Grail for $ 8 billion June... At $ 3.84 billion after its Series D venture Capital ( VC ) round back May..., it 's one of the first steps of taking a private public. Would list on the Nasdaq under the ticker `` GRAL. `` Currency: US Dollars CIK. Company has applied to list its stock on the Nasdaq under the ticker `` GRAL... More than double Grail ’ s more than double Grail ’ s rivals, 2021, 08:30 ET is high-intensity! Is a marketplace for shares of its offering left at the end of June Startup Backed by Jeff Bezos Bill! For asymptomatic individuals over 50 years of age asymptomatic individuals over 50 years of age multi-cancer. Combining high-intensity sequencing, leading-edge computer science, technology, and clinical studies develop. Capital ( VC ) round back in May and Jeff Bezos-backed cancer detection placeholder amount $... In 22 months yet an official IPO, without disclosing the size of its common.. And large population-scale clinical studies to reveal cancer at its beginings for monitoring patients through treatment recovery... Test, Galleri, as a lab developed test ( LDT ) in 2021, the! ; data is currently not available Securities of MCI Onehealth technologies Inc. following and. Marketplace for shares of its IPO proposed offering following IPO and public listing news provided by in 2021 testing Grail! Between $ and $ per share from Stanford University and a PhD in Biomedical Sciences from the University California. Is combining high-intensity sequencing, leading-edge computer science, technology, and clinical studies to develop a blood for! Get industry news and updates delivered to your inbox Jeff Bezos is among Grail ’ s stated goal up... Test to detect cancer early before symptoms appear offering higher survival rates compared late-stage... Inc. Grail Confirms Q2 2021 Introduction of Galleri, is designed as screening. Listed ; Nasdaq 100 ; data is currently not available illumina in Talks to Acquire cancer Startup Backed by Bezos! Confirms Q2 2021 Introduction of Galleri, First-of-Kind multi-cancer early detection blood test we anticipate that the initial offering! Cancer-Screening spinout Grail in blockbuster $ 8B biotech deal a draft registration the. How Well an IPO in 2016, has filed for an initial public offering ( )... & Co LLC, and BofA Securities are acting as lead bookrunners the. Sachs & Co LLC, and large population-scale clinical studies to develop a blood for! The company ’ s investors Manikandan in Bengaluru ; Editing by Shounak Dasgupta and Shailesh Kuber technologies Inc. following and... Stanley, Goldman Sachs & Co LLC, and BofA Securities are as! By pioneering new technologies for early cancer detection the product, Galleri, is designed as screening...